Business
Appointment of Roland Diggelmann as Non-Exec. Dir.
Appointment of Roland Diggelmann as Non-Exec. Dir..
About this update from Smith & Nephew Plc
[{"type":"text","content":"\n \nRNS Number : 4610D Smith & Nephew Plc 31 January 2018 \n\n \nAppointment of Roland Diggelmann as Non-Executive Director\n31 January 2018\nSmith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces that Roland Diggelmann is to join its Board as Non-Executive Director on 1 March 2018. \nRoland Diggelmann, Chief Executive Officer at Roche Diagnostics and a member of the Corporate Executive Committee of F. Hoffmann-La Roche Ltd, joined Roche in 2008 as Head Region Asia Pacific, and was appointed to his current role in 2012. Prior to Roche, he was Managing Director for Japan and later Executive Vice President Sales/Distribution EMEA and Managing Director for Zimmer GmbH. Before Zimmer he worked for Sulzer Orthopedics Ltd and Sulzer Medical/Centerpulse Ltd in Europe and Asia Pacific, prior to its acquisition by Zimmer.\nRoland Diggelmann is a Swiss citizen, born in 1967, and studied Business Administration at University of Berne, Switzerland.\nRoberto Quarta, Chairman of Smith & Nephew, commented:\n\"As we have said previously, we have been looking to strengthen our Board with a Non-Executive Director who has direct experience in our orthopaedic field of medical devices. Roland Diggelmann brings that experience to the Board, having held senior positions at Sulzer Orthopaedics and then with Zimmer. He has also had significant international experience, particularly in Japan and other parts of Asia, important markets for Smith & Nephew. We are delighted that he will be joining our Board and look forward to his insights into our industry.\" \nNo disclosure obligations arise under paragraphs (1) to (6) of LR 9.6.13 R of the UK Listing Authority's Listing Rules in respect of this appointment. Mr Diggelmann's fees will be $129,780 per annum of which $9,780 will be paid in the form of Smith & Nephew shares in-line with current Non-Executive Directors. \n- ends -\n Enquiries \n\n\n\n\nInvestors\nIngeborg Oie\nSmith & Nephew\n\n\n \n+44 (0) 20 960 2285\n\n\n\n\nMedia\nCharles Reynolds\nSmith & Nephew\n\n\n\n+44 (0) 1923 477314\n\n\n\n\nBen Atwell / Simon Conway\nFTI Strategic Consulting\n\n\n+44 (0) 20 3727 1000\n\n\n\n\n \n\nAbout Smith & Nephew\nSmith & Nephew is a global medical technology business dedicated to helping healthcare professional...